Aldesleukin Completed Phase 2 Trials for Stage IV Breast Cancer / Male Breast Cancer / HER2 Positive Breast Cancers / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00006228Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer